J&J Files 8-K on Financials and Debt

Ticker: JNJ · Form: 8-K · Filed: 2024-07-17T00:00:00.000Z

Sentiment: neutral

Topics: debt, financials, disclosure

Related Tickers: JNJ

TL;DR

J&J dropped an 8-K on July 17th detailing their debt notes – keep an eye on those maturities.

AI Summary

On July 17, 2024, Johnson & Johnson filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various debt instruments, such as their $5.50 Notes due 2024 and $1.150 Notes due November 2028, indicating ongoing financial management and potential refinancing activities.

Why It Matters

This filing provides insight into Johnson & Johnson's current financial structure and debt obligations, which can influence investor confidence and the company's future borrowing capacity.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial information and debt instruments, not indicating any immediate or significant operational risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Johnson & Johnson?

The primary purpose of this 8-K filing is to report on Johnson & Johnson's results of operations and financial condition, as well as to include financial statements and exhibits.

What specific debt instruments are mentioned in the filing?

The filing mentions several debt instruments including $5.50 Notes due 2024, $1.150 Notes due November 2028, $3.20 Notes due November 2032, $1.650 Notes due 2035, $3.350 Notes due November 2036, and $3.550 Notes due November 2044.

When was this 8-K report filed?

This 8-K report was filed on July 17, 2024.

What is Johnson & Johnson's state of incorporation?

Johnson & Johnson's state of incorporation is New Jersey.

What is the business address and phone number provided for Johnson & Johnson?

The business address is One Johnson & Johnson Plaza, New Brunswick, NJ 08933, and the business phone number is 732-524-2455.

From the Filing

0000200406-24-000071.txt : 20240717 0000200406-24-000071.hdr.sgml : 20240717 20240717081426 ACCESSION NUMBER: 0000200406-24-000071 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240717 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 241120994 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20240717.htm 8-K jnj-20240717 0000200406 false 0000200406 2024-07-17 2024-07-17 0000200406 us-gaap:CommonStockMember 2024-07-17 2024-07-17 0000200406 jnj:A5.50NotesDue2024Member 2024-07-17 2024-07-17 0000200406 jnj:A1.150NotesDueNovember2028Member 2024-07-17 2024-07-17 0000200406 jnj:A3.20NotesDueNovember2032Member 2024-07-17 2024-07-17 0000200406 jnj:A1.650NotesDue2035Member 2024-07-17 2024-07-17 0000200406 jnj:A3.350NotesDueNovember2036Member 2024-07-17 2024-07-17 0000200406 jnj:A3.550NotesDueNovember2044Member 2024-07-17 2024-07-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  July 17, 2024 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 5.50% Notes Due November 2024 JNJ24BP New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 3.20% Notes Due November 2032 JNJ32 New York Stock Exchange 1.650% Notes Due May 2035 JNJ35 New York Stock Exchange 3.350% Notes Due November 2036 JNJ36A New York Stock Exchange 3.550% Notes Due November 2044 JNJ44 New York Stock Exchange Item 2.02 Results of operations and financial condition On July 17, 2024, Johnson &

View on Read The Filing